Clarithromycin

Clarithromycin is a semi-synthetic macrolide antibiotic derived from erythromycin. It is used for respiratory tract infections, skin infections, H. pylori eradication (in combination therapy), and MAC (Mycobacterium avium complex) infections in immunocompromised patients. Mediocon Inc supplies pharmaceutical-grade Clarithromycin meeting IP/BP/EP/USP standards.

Key Features

• Semi-synthetic macrolide antibiotic
• IP/BP/EP/USP compliant, Assay 99.0% Min.
• Effective against atypical and intracellular organisms
• Suitable for oral tablet and extended-release formulations

Applications

• Community-acquired pneumonia treatment
• H. pylori eradication triple therapy
• MAC infections in HIV patients
• Extended-release oral tablet formulations

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings